Susquehanna Fundamental Investments, LLC Acadia Pharmaceuticals Inc Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $258,057 - $334,140	18,289 Added 34.76%	70,900 $1.16 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $103,632 - $136,097	-4,949 Reduced 8.6%	52,611 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $966,432 - $1.56 Million	57,560 New	57,560 $1.34 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $942,034 - $1.48 Million	-59,698 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$19.4 - $27.42 $440,806 - $623,037	22,722 Added 61.45%	59,698 $1.46 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $925,139 - $2.03 Million	36,976 New	36,976 $954,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $3.23 Million - $4.46 Million	-78,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $3.09 Million - $4.14 Million	78,600 New	78,600 $3.81 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.